You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ineligible for cardiac transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • VRD
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 5, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Multiple Myeloma Trial in Cologne (Daratumumab)

Recruiting
  • Multiple Myeloma
  • Cologne, Germany
    University of Cologne
Apr 4, 2022

Cardiac Resynchronization Therapy, Heart Failure Trial (Conduction system pacing, Biventricular pacing)

Not yet recruiting
  • Cardiac Resynchronization Therapy
  • Heart Failure
  • Conduction system pacing
  • Biventricular pacing
  • (no location specified)
Oct 26, 2023

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Rochester, New York
    University of Rochester Medical Center
Jul 8, 2022

Multiple Myeloma Trial in Oslo, Stavanger, Trondheim (Isatuximab, bortezomib, lenalidomide, dexamethason)

Recruiting
  • Multiple Myeloma
  • Isatuximab, bortezomib, lenalidomide, dexamethason
  • Roskilde, Denmark
  • +3 more
Sep 20, 2022

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
  • Cardio-oncology program
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 6, 2023

Heart Transplant Trial in Omaha (Evolocumab (Repatha))

Active, not recruiting
  • Heart Transplant
  • Evolocumab (Repatha)
  • Omaha, Nebraska
    University of Nebraska Medical Center
Dec 15, 2022

Liver Transplant With VEnaRt Cardiac Output Versus Swan-Ganz

Recruiting
  • Cardiac Output, Low
  • Liver Transplant; Complications
  • VEnaRt Cardiac Output
  • Udine, Italy
    Anesthesiology and Intensive Care Clinic - Department of Medicin
Nov 5, 2022

Life-threatening, Biventricular Heart Failure, Ineligible for Cardiac Transplant Trial in United States (70cc TAH-t for

Recruiting
  • Life-threatening
  • +2 more
  • 70cc TAH-t for Destination Therapy
  • Phoenix, Arizona
  • +6 more
Mar 16, 2021

Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

Not yet recruiting
  • Transplant; Failure, Heart
  • +2 more
  • (no location specified)
Nov 19, 2023

Cardiac Transplant Metabolomics

Not yet recruiting
  • Heart Transplant Rejection
  • Extra blood samples (5-10 mL) drawn
  • (no location specified)
Mar 17, 2023

Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Not yet recruiting
  • Heart Transplant Failure
  • Anesthesia
  • Lung Recruitment
  • (no location specified)
Nov 27, 2023

Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Mar 4, 2022

Lenalidomide / Dexamethasone as First Line Therapy in Multiple

Active, not recruiting
  • Multiple Myeloma
    • Bochum, Germany
      Hämatologisch-Onkologische Schwerpunktpraxis
    Feb 1, 2022

    Mechanical Unloading on Repair Version-1

    Completed
    • Heart Failure
    • Transplant; Failure, Heart
      • (no location specified)
      Sep 4, 2023

      Cardiac Allograft Vasculopathy Trial in Seoul

      Recruiting
      • Cardiac Allograft Vasculopathy
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Sep 6, 2022

        Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)

        Not yet recruiting
        • Heart Transplant
        • +2 more
        • HeartCare
        • (no location specified)
        Jul 12, 2022

        Heart Transplantation Trial in Los Angeles (Thymoglobulin, Mycophenolate Mofetil, Tacrolimus)

        Enrolling by invitation
        • Heart Transplantation
        • Los Angeles, California
        • +1 more
        Nov 11, 2022

        Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

        Recruiting
        • Multiple Myeloma
        • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
        • +7 more
        Jan 9, 2023

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Ibrutinib, Laboratory

        Suspended
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Jacksonville, Florida
          Mayo Clinic in Florida
        Mar 22, 2022